Keratin 7 Proteins (KRT7)

The protein encoded by KRT7 is a member of the keratin gene family. Additionally we are shipping Keratin 7 Antibodies (800) and Keratin 7 Kits (6) and many more products for this protein.

list all proteins Gene Name GeneID UniProt
KRT7 3855 P08729
KRT7 110310 Q9DCV7
KRT7 300242 Q6IG12
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top Keratin 7 Proteins at antibodies-online.com

Showing 8 out of 12 products:

Catalog No. Origin Source Conjugate Images Quantity Supplier Delivery Price Details
Escherichia coli (E. coli) Human His tag „Crystallography Grade“ protein due to multi-step, protein-specific purification process 1 mg Log in to see 30 to 35 Days
$5,370.21
Details
Escherichia coli (E. coli) Mouse His tag „Crystallography Grade“ protein due to multi-step, protein-specific purification process 1 mg Log in to see 30 to 35 Days
$5,370.21
Details
Escherichia coli (E. coli) Human Un-conjugated SDS-PAGE analysis of Human Keratin 7 Protein. 100 μg Log in to see 11 to 18 Days
$668.03
Details
Wheat germ Human GST tag 10 μg Log in to see 11 to 12 Days
$414.29
Details
Escherichia coli (E. coli) Rat His tag   100 μg Log in to see 15 to 18 Days
$608.00
Details
Yeast Cow His tag   1 mg Log in to see 60 to 71 Days
$3,309.17
Details
Yeast Chimpanzee His tag   1 mg Log in to see 60 to 71 Days
$3,318.33
Details
Escherichia coli (E. coli) Human Un-conjugated   5 applications Log in to see 1 to 2 Days
$318.85
Details

KRT7 Proteins by Origin and Source

Origin Expressed in Conjugate
Human ,
,
Mouse (Murine)

Rat (Rattus)

More Proteins for Keratin 7 (KRT7) Interaction Partners

Human Keratin 7 (KRT7) interaction partners

  1. MUC-1, CK7, and c-p27 immunostaining can be used as the predictive markers for esophageal cancer progression from Barrett's esophagus.

  2. CK7, unlike p16, is not useful as a prognostic biomarker in cervical intraepithelial neoplasia 2, but is still a useful prognostic marker for cervical intraepithelial neoplasia 1.

  3. Data indicate that de novo expression of KRT7 and KRT19 resulting in altered plasticity and stem cell characteristics of epithelial cells might be a crucial factor in increasing the risk of tumor development in end-stage kidneys.

  4. High expression of CK-7 is associated with intrahepatic cholangiocarcinoma.

  5. Positive expression of CK7 associated with pathological features of lymph node metastasis and T stage may be independent clinical parameters for poor prognosis of patients with lung cancer.

  6. Research show that circulating CK7 mRNA positive cells were found in patients with bladder urothelial cancer of varying stages, and the detection rates increased with stage predicting worse clinical scenario.

  7. CK7/ HPV-L1 expression, and the presence of koilocytosis can be used for prognostication in patients with cervical low-grade squamous intraepithelial lesions.

  8. KRT7-AS formed an RNA-RNA hybrid with KRT7 and controlled KRT7 expression at both the mRNA and the post-transcriptional levels. forced overexpression of the KRT7-overlapping region (OL) of KRT7-AS (but not its non-KRT7-OL portions) increased keratin 7 protein levels in cells. Finally, forced overexpression of full-length KRT7-AS or OL KRT7-AS (but not its non-KRT7-OL regions) promoted GC cell proliferation

  9. These data support the theory that CK7 staining may inform risk stratification for low-grade squamous intraepithelial cervical lesions (CIN1).

  10. the status of K7 expression in metastatic lymph nodes from colorectal carcinoma is a poor prognostic factor

  11. Mismatch repair (MMR) defects influence the expression of clinically important biomarkers for endometrioid-type endometrial carcinoma as decreased cytokeratin 7 expression is more commonly associated with MMR deficiency.

  12. Ischemic parenchymal changes are characterized by hepatocyte K7 immunoexpression

  13. Survival analysis showed that the non-small cell lung carcinoma patients with enhanced expression of CK7, ELF3, EGFR, and EphB4 mRNA in peripheral blood leukocytes had poorer disease-free survival and overall survival than those without.

  14. Immunocytochemistry using this antibody cocktail comprises five antibodies recognising p63, and cytokeratins ( 7, 18, 5 and 14) showed good sensitivity and specificity for diagnosing breast cancers. Thus, this method is useful for mammary cytology using FNA

  15. Keratin 34betaE12/K7 expression is a prognostic parameter in resected early stage NSCLC that allows identification of high-risk NSCLC patients with poor cancer-specific and overall survival.

  16. K7 expression was also detected in 72 of 75 triple-negative carcinoma cases

  17. CK7, TTF-1 and napsin A are predominantly expressed in primary lung adenocarcinoma patients, with CDX-2 being inconsistently expressed.

  18. CK7 staining was notably heterogeneous, with 14.5% of all cases demonstrating

  19. Data show that cytokeratin-7 (KRT7) mRNA expression serves as a sensitive approach for the molecular detection of KRT7-positive circulating tumour cells (CTCs)-resembling A549 cells in peripheral whole blood.

  20. Cytokeratin 7 positivity in cervical low-grade squamous intraepithelial lesion is a marker for risk of progression to a high-grade lesion.

Mouse (Murine) Keratin 7 (KRT7) interaction partners

  1. Keratin-7 deficiency resulted in increased proliferation of the bladder urothelium, although this was not associated with hyperplasia.

  2. The -0.25 kb region of keratin 7 promoter showed pancreatic selectivity, high activity in pancreatic cancers, & sustained transgene expression in xenografts. krt7 promoter is useful to target pancreatic ductal adenocarcinoma cells in vitro and in vivo.

Keratin 7 (KRT7) Protein Profile

Protein Summary

The protein encoded by this gene is a member of the keratin gene family. The type II cytokeratins consist of basic or neutral proteins which are arranged in pairs of heterotypic keratin chains coexpressed during differentiation of simple and stratified epithelial tissues. This type II cytokeratin is specifically expressed in the simple epithelia lining the cavities of the internal organs and in the gland ducts and blood vessels. The genes encoding the type II cytokeratins are clustered in a region of chromosome 12q12-q13. Alternative splicing may result in several transcript variants\; however, not all variants have been fully described.

Gene names and symbols associated with Keratin 7 Proteins (KRT7)

  • keratin 7 (KRT7)
  • keratin 7 (Krt7)
  • CK7 protein
  • D15Wsu77e protein
  • K2C7 protein
  • K7 protein
  • Krt2-7 protein
  • KRT7 protein
  • SCL protein

Protein level used designations for Keratin 7 Proteins (KRT7)

keratin 7 , keratin, type II cytoskeletal 7-like , CK-7 , cytokeratin 7 , cytokeratin-7 , keratin, 55K type II cytoskeletal , keratin, simple epithelial type I, K7 , keratin, type II cytoskeletal 7 , keratin-7 , sarcolectin , type II mesothelial keratin K7 , type-II keratin Kb7 , Cytokeratin 7 , keratin complex 2, basic, gene 7 , K7 , type II keratin Kb7

GENE ID SPECIES
100062790 Equus caballus
100394518 Callithrix jacchus
3855 Homo sapiens
110310 Mus musculus
300242 Rattus norvegicus
535697 Bos taurus
101112716 Ovis aries
466983 Pan troglodytes
477602 Canis lupus familiaris
Selected quality suppliers for Keratin 7 Proteins (KRT7)
Did you look for something else?